Reading time is 4 mins


Zygoma, that is, cheekbone implants, is the most effective solution for patients with bone resorption in their upper jaw that cannot be performed with a standard dental implant

Prosthetic teeth and implant placement in patients with extremely molten upper jaw bone is a difficult procedure for both surgeons and prosthetics specialists. If only conventional implants are to be used in patients with melted upper jaw bone, bone grafting may often be required before placing the implant in the area where the implant will be applied. This procedure usually involves raising the base of the sinus and performing bone grafts.

In these applications, the fact that the treatment is laborious and difficult, the long duration of treatment, the costs and potential complications are important considerations. These are also important factors that cause patients to turn away from treatment.

Zygoma (cheekbone) implants are performed for patients who have had bone resorption in their upper jaw, as standard dental implant technique cannot be applied.

Zigoma implants are implants that are made in the form of regular implants, but much longer than them. Their length is from 05 to 50 mm.

Zygoma implants are placed, usually under general anesthesia, sometimes with local anesthesia. It is a slightly more difficult application than normal implant application.


Bone grafting methods are often avoided with zygoma (cheekbone) implants, and patients may continue to use a temporary prosthesis for the duration of treatment.

Zygomatic implants, when used properly, provide an alternative treatment option for many patients with fused upper jaw bone.

The success of traditional implants applied to the upper jaw bone can be controversial depending on the amount and quality of the bone.

Especially in patients with severely fused upper jaw bone or in patients who have had part or all of the upper jaw bone removed due to tumors, zygomatic implants have been an alternative to extensive surgical procedures in recent years.

The main support of these implants, the length of which is from 45 mm to 55 mm, is provided by fixation to the cheekbone.

The surgical protocol for zygoma implants requires a highly skilled surgeon or extensive navigation techniques.

The main indications for implants of this particular type are as follows:

Maxillectomies performed after tumors (removal of the upper jaw bone),

Failures in the practice of providing bone in the upper jaw with bone grafts,

In order to avoid the practice of providing bone in the upper jaw with bone grafts.

The cheekbone is an excellent area for implants to hold on and provide support for the prosthesis. Most anatomical studies have confirmed this condition. The researchers agreed that the quality of the cheekbone is superior to the quality of the bone in the posterior region of the upper jaw. This, in turn, allows the applied implant to hold on to the bone more strongly.

The most important complications in the treatment with zygomatic implants are the loss of implants.

Experience to date has shown that this condition occurs infrequently, but nevertheless, its effects on the planning should not be underestimated. With the loss of the zygoma implant, there may be serious problems with receiving support from the posterior region, excessive forces may be applied to other implants. As a result, a second implant may need to be re-inserted into the same area to correct the resulting imbalance.


Today, thanks to additional implants applied together with zygomatic implants, stabilization of prostheses applied to the upper jaw is achieved. But in order for this application to be performed, the amount of bone in the anterior region of the upper jaw should allow two, preferably four, conventional implants to be placed. In addition, there should be no infection in the sinuses of the patients and there should be an acceptable amount of soft tissue in the area where the implants will be placed. Treatment planning of patients should be carried out before the placement of implants. The patient’s medical and physical condition should be at a level that tolerates a two-hour surgical procedure and general anesthesia or deep sedation. The patient’s mouth opening should allow the placement of zygomatic implants with a length of 30 mm to 52.5 mm.


Final measurement procedures can usually be performed after three to four weeks following an appropriate recovery period. The procedure of this stage also follows a similar path as in the case of the construction of a fixed bridge on implants. After laboratory procedures, threaded rehearsals are performed and the patient is expected to give approval from an aesthetic point of view. According to clinical studies reported by many researchers, the success of zygomatic implants is reported to range from 82 to 100 percent. In the light of the studies conducted on zygomatic implants, we can say that zygomatic implants can be successfully applied to restore function, phonation and aesthetics in patients with advanced molten upper jaw bone and partial loss of upper jaw as a result of tumor surgery.


After the Zygoma (cheekbone) implant is made, the conditions that need to be paid attention to after the normal implant application are applied exactly. Patients need to take the prescribed medications regularly and not eat hot food for several days. Zygoma implant, patients should not eat hard foods under any circumstances during periods of temporary prosthetics. Patients must necessarily be fed a soft diet. This is due to the fact that the load on the dental implants is reduced. In permanent prostheses made after three months, they can start normal food consumption. Another important point is that if a fracture occurs in temporary dentures, you should definitely visit the dentist clinic in Turkey. Otherwise, broken prostheses can lead to implant loss.


A Zygoma implant can be a very fast and reliable solution in cases where traditional implant application cannot be performed because there is not enough maxillary bone.

Severe bone turnover (applied to patients; it is a long process, and a relatively low success rate without the need of bone grafting procedure with much shorter treatment time and higher treatment success rate of implantation can be performed.

It can be applied to patients who have undergone extensive resections in the premaxilla due to reasons such as accident, cancer disease.

Dental patients who have had a zygoma implant can get their best prostheses in a much shorter time compared to conventional dental implant therapies in Turkey.


Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.


Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.


Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.


Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)